Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors reverses subcronic PCP-induced deficits in the novel object recognition task in rats
Research output: Contribution to journal › Journal article › Research
Standard
Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors reverses subcronic PCP-induced deficits in the novel object recognition task in rats. / Nielsen, Trine Damgaard; Larsen, Dorrit Bjerg ; Hansen, Suzanne Lisbet; Grayson, Ben; Neill, Jo C.; Plath, Niels.
In: Behavioural Brain Research, Vol. 207, No. 1, 11.02.2010, p. 144-150.Research output: Contribution to journal › Journal article › Research
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors reverses subcronic PCP-induced deficits in the novel object recognition task in rats
AU - Nielsen, Trine Damgaard
AU - Larsen, Dorrit Bjerg
AU - Hansen, Suzanne Lisbet
AU - Grayson, Ben
AU - Neill, Jo C.
AU - Plath, Niels
PY - 2010/2/11
Y1 - 2010/2/11
N2 - Cognitive deficits are a major clinical unmet need in schizophrenia. The psychotomimetic drug phencyclicline (PCP) is widely applied in rodents to mimic symptoms of schizophrenia, including cognitive deficits. Precious studies have shown that sub-chronic PCP induces an enduring episodic memory deficit in female Lister hooded rats in teh novel object recognition (NOR) task. Here we show that positive modulation of AMPA receptor (AMPAR) mediated glutamate transmission alleviates cognitive deficits induced by sub-chronic PCP treatment. Female Lister hooded rats were treated sub-cronically with either vehicle (0.9% saline) or PCP (2mg/kg two doses per day for 7 days), followed by a 7 days washout period. 30 min prior to the acquisition trial of the NOR task animals were dosed with either vehicle, CX546 (10, 40, or 80 mg/kg) or CX516 (0.5, 2.5, 10, 40, or 80 mg/kg). Our results show that sub-cbronic PCP treatment induced a significant decrease in the discrimination index (DI) and both ampakines CX546 and CX516 were able to reverse this diruption of object memory in rats in the novel object recognition task. These data suggest that positive AMPAR modulation may represent a mechanism for treatment of cognitive deficits in schizophrenia. (C) 2009 Elsevier B.V. All rights reserved.
AB - Cognitive deficits are a major clinical unmet need in schizophrenia. The psychotomimetic drug phencyclicline (PCP) is widely applied in rodents to mimic symptoms of schizophrenia, including cognitive deficits. Precious studies have shown that sub-chronic PCP induces an enduring episodic memory deficit in female Lister hooded rats in teh novel object recognition (NOR) task. Here we show that positive modulation of AMPA receptor (AMPAR) mediated glutamate transmission alleviates cognitive deficits induced by sub-chronic PCP treatment. Female Lister hooded rats were treated sub-cronically with either vehicle (0.9% saline) or PCP (2mg/kg two doses per day for 7 days), followed by a 7 days washout period. 30 min prior to the acquisition trial of the NOR task animals were dosed with either vehicle, CX546 (10, 40, or 80 mg/kg) or CX516 (0.5, 2.5, 10, 40, or 80 mg/kg). Our results show that sub-cbronic PCP treatment induced a significant decrease in the discrimination index (DI) and both ampakines CX546 and CX516 were able to reverse this diruption of object memory in rats in the novel object recognition task. These data suggest that positive AMPAR modulation may represent a mechanism for treatment of cognitive deficits in schizophrenia. (C) 2009 Elsevier B.V. All rights reserved.
KW - Former Faculty of Pharmaceutical Sciences
KW - Schizophrenia
KW - Cognition
KW - Phencyclidine
KW - Ampakines
KW - Novel object recognition
KW - Rats
U2 - 10.1016/j.bbr.2009.09.048
DO - 10.1016/j.bbr.2009.09.048
M3 - Journal article
C2 - 19822174
VL - 207
SP - 144
EP - 150
JO - Behavioural Brain Research
JF - Behavioural Brain Research
SN - 0166-4328
IS - 1
ER -
ID: 34205810